Thermostable group II intron reverse transcriptases and their applications in next generation RNA sequencing, diagnostics, and precision medicine

dc.contributor.advisorLambowitz, Alan
dc.contributor.committeeMemberIyer, Vishwanath R
dc.contributor.committeeMemberKrug, Robert M
dc.contributor.committeeMemberRussell, Rick
dc.contributor.committeeMemberStevens, Scott W
dc.contributor.committeeMemberSullivan, Christopher S
dc.creatorQin, Yidan
dc.date.accessioned2016-10-12T15:54:51Z
dc.date.accessioned2018-01-22T22:30:44Z
dc.date.available2016-10-12T15:54:51Z
dc.date.available2018-01-22T22:30:44Z
dc.date.issued2016-05
dc.date.submittedMay 2016
dc.date.updated2016-10-12T15:54:52Z
dc.description.abstractThermostable group II intron reverse transcriptases (TGIRTs) from thermophilic bacteria are advantageous for biotechnological applications that require cDNA synthesis, such as RT-qPCR and RNA-seq. TGIRTs have higher thermostability, processivity and fidelity than conventional retroviral RTs, along with a novel end-to-end template-switching activity that attaches RNA-seq adapters to target RNAs without RNA ligation. First, I optimized the TGIRT template-switching method for RNA-seq analysis of small non-coding RNAs (ncRNAs). I showed that TGIRT-seq gives full-length reads of tRNAs, which are refractory to retroviral RTs, and enables identification of a variety of base modifications in tRNAs by distinctive patterns of misincorporated nucleotides. With collaborators, I developed an efficient and quantitative high-throughput tRNA sequencing method, identified RNAs bound by the human interferon-induced protein IFIT5, yielding new insights into its functions in tRNA quality control and innate immunity, and uncovered a novel mRNA-independent mechanism for elongation of nascent peptides. Second, I developed a new, streamlined TGIRT-seq method for comprehensive analysis of all RNA size classes in a single RNA-seq. This method enables RNA-seq library construction from <1 ng of fragmented RNAs in <5 h. By using the method, I showed that human plasma contains large numbers of protein-coding and long ncRNAs together with diverse classes of small ncRNAs, which are mostly present as full-length transcripts. With collaborators, I showed that TGIRT-seq analysis of circulating RNAs identified potential biomarkers at different stages of multiple myeloma and may provide a sensitive, non-invasive diagnostic tool for a variety of human diseases. Finally, I adapted TGIRTs for use in mapping of RNA structures and RNA-protein interaction sites, and identification of RNA targets of cellular RNA-binding proteins. My research led to a series of new biological insights, which would have been difficult or impossible to obtain by current methods, and established TGIRTs as a tool for a broad range of applications in RNA research and diagnostics.
dc.description.departmentMicrobiology
dc.format.mimetypeapplication/pdf
dc.identifierdoi:10.15781/T2SN01588
dc.identifier.urihttp://hdl.handle.net/2152/41602
dc.language.isoen
dc.subjectRNA-seq
dc.subjectDiagnostics
dc.subjectPrecision medicine
dc.subjectNon-coding RNA
dc.subjectCirculating RNA
dc.titleThermostable group II intron reverse transcriptases and their applications in next generation RNA sequencing, diagnostics, and precision medicine
dc.typeThesis
dc.type.materialtext

Files